Article
Next-Generation Bruton’s tyrosine kinase Inhibitors plus Rituximab for Chronic Lymphocytic Leukemia-associated Membranoproliferative Glomerulonephritis: A Case Report
2025-12-02
Abstract excerpt
<title>Abstract</title> <p>Renal involvement in chronic lymphocytic leukemia (CLL) is rare but clinically significant. Among the various pathological types, membranoproliferative glomerulonephritis (MPGN) is the most common and often presents as nephrotic syndrome. Early recognition of the association between renal lesions and CLL is crucial for guiding treatment and improving both renal and hematologic outcomes....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 73341aae-2b4c-5e50-939d-4f2f2e7dd746
- DOI
- 10.21203/rs.3.rs-8195069/v1
